OHDSI Home | Forums | Wiki | Github

OHDSI virtual study-a-thon to support COVID-19 response, to take place 26-29Mar2020...Collaborators wanted!

General
#36

Working on that.

Exactly. Will create alternative outcome cohorts (= endpoints) and study potential discrepancies.

2 Likes
#37

The registration form says that no further registrations for the study-a-thon are possible :confused: is that correct or a technical error?

#38

I have the same question since it is being locked. How to contribute to the StudyAThon?

#39

I would also like to be able to contribute terminology support from CIEL if it is still possible. I am coordinating with other COVID response, but would like to be able drop in to help out on the ETL or terminology challenges.

#40

It seems that Google form is not active any more. Is that intentional? Is there still a way to join on March 24?

#41

Hi @ZKostic, unfortunately, registration has closed on the study-a-thon. However, this is only the beginning of OHDSI’s research agenda around the COVID-19 pandemic. You can get a sense of the planned studies from this recent forum post, and then follow along on the forum, our COVID-19 updates page, or on our Twitter or LinkedIn feeds. We hope you will consider collaborating with our community on the many future efforts to support healthcare decision-making.

Best,
Craig

#42

Hi @Qubit,
Unfortunately, registration has closed on the study-a-thon. However, this is only the beginning of OHDSI’s research agenda around the COVID-19 pandemic. You can get a sense of the planned studies from this recent forum post, and then follow along on the forum, our COVID-19 updates page, or on our Twitter or LinkedIn feeds. We hope you will consider collaborating with our community on the many future efforts to support healthcare decision-making.

Best,
Craig

#43

Hi @CJ_Hameed,
Unfortunately, registration has closed on the study-a-thon. However, this is only the beginning of OHDSI’s research agenda around the COVID-19 pandemic. You can get a sense of the planned studies from this recent forum post, and then follow along on the forum, our COVID-19 updates page, or on our Twitter or LinkedIn feeds. We hope you will consider collaborating with our community on the many future efforts to support healthcare decision-making.

Best,
Craig

1 Like
#44

Hi @Andy_Kanter,
Unfortunately, registration has closed on the study-a-thon. However, this is only the beginning of OHDSI’s research agenda around the COVID-19 pandemic. You can get a sense of the planned studies from this recent forum post, and then follow along on the forum, our COVID-19 updates page, or on our Twitter or LinkedIn feeds. We hope you will consider collaborating with our community on the many future efforts to support healthcare decision-making.

Best,
Craig

#45

Hi everyone,

Thank you for this great initiative! I am Lotte Geys and I work as a community manager for the Multiple Sclerosis Data Alliance (MSDA).
To reduce symptoms in MS patients, disease-modifying therapies (DMT’s) are given, but these therapies are often immune-suppressants. Since we would like to inform our MS patients (whether or not infected with SARS-COV2) in the best possible way about whether they should stop or change their DMT’s, we have the following urgent question:
Is there an increased risk of severe COVID-19 outcomes when using immune-suppressing drugs?

Apart from MS patients there are of course other immunocompromised patients. It would be of interest if anyone could share his/her experience with COVID19 in patients suffering from other immune-diseases on different medications as well, or oncology patients that are immune-suppressed.

Additionally, will we be able to ask and discuss such questions during the COVID-19 study-a-thon of the upcoming days?

Thanks!

#47

Hi Patrick, I have registered this study group. But I did not get an email from Microsoft Teams OHDSI-COVID-19 with instructions for how to log on. May you or other team member send me that invitation email. My email is weihua.gao@abbvie.com. Thanks!

#48

Hi @gaowx3, I have reached out to the group running the @MSTeams account and asked them to re-send the email. It might be in the morning, though. I do see you registered, so you are in.

#49

Thank you for the prompt response!

#50

The Korean government launched the distributed research network project for COVID-19
#opendata4covid19

5 Likes
#51

It is spectacular for the Korean government to do this! It will be a great help for the entire world and hopefully accelerate the control of COVID-19. Everyone everywhere is waiting for the evidence that the data will generate. OHDSI is very pleased to assist them in analyzing the data.

#52

Thank you Chan. This is a great resource. Can you only access the data via R and SAS or can you also use other tools? ML? NLP? Python?

#53

Is it the Korean Government, or Chan convincing the Korean Government? :slight_smile:
Either way: it’s an example for the world.

1 Like
#54

That’s great news Chan! Do you know when it will be available and how individuals can get access?

#55

Hi everyone!

Apparently there has been some oncology-related questions during the OHDSI COVID-19 studyathon, so this message is mainly for those people interested in COVID&CANCER:

The OncologyWG is organizing a Covid-Oncology use case session next week to mainly:

  1.  Assess available data on COVID-19 in relation to cancer;

  2.  Overview the clinical use cases on cancer patients in relation with COVID-19;

  3.  Identify matches between data and use case, and an action plan to perform a study.

In case you’re interested in contributing or you’d like to know more about it, feel free to drop me a message!

Cheers,
Chiara

1 Like
#56

@CraigSachson I also registered and haven’t gotten any emails from @MSTeams. Is it possible to check and make sure I’m registered? I seem to be having some problems receiving the emails–it might be better to use my personal email, juliannamkohler@gmail.com.

t